Jessica Gambardella1,2,3, Antonella Fiordelisi1, Luca Spigno4, Lorenzo Boldrini4, Giulia Lungonelli4, Eugenio Di Vaia1, Gaetano Santulli1,2,3, Daniela Sorriento1,5, Federica Andrea Cerasuolo6, Valentina Trimarco5,6, Guido Iaccarino1,5. 1. Department of Advanced Biomedical Sciences, Federico II University of Naples, Italy. 2. Department of Medicine, Wilf Family Cardiovascular Research Institute, Einstein-Institute for Aging Research, Albert Einstein College of Medicine, New York, NY 10461, USA. 3. Department of Molecular Pharmacology, Fleischer Institute for Diabetes and Metabolism (FIDAM), Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Albert Einstein College of Medicine, New York, NY 10461, USA. 4. Clinical and Sports Nutrition Service, Villa Montallegro Hospital, Genova, Italy. 5. CIRIAPA Interdepartmental Center for Research on Arterial Hypertension and Associated Conditions, Federico II University of Naples, Italy. 6. Department of Neurosciences, Federico II University of Naples, Italy.
Abstract
BACKGROUND: Ergogenic nutritional supplementation is sought by professional athletes for improving physical performance; nevertheless, scientific evidence to support the chronic use of L-Arginine among water polo players is missing. METHODS: Seventeen male professional water polo players were randomly assigned to assume 5 grams per day of L-Arginine (n = 9) or placebo (n = 8) for 4 weeks. The players' fitness level was assessed in the maximal speed swimming test. Ear lobe blood samples taken before and after the effort for serum lactate content were analyzed. A speed-to-lactate ratio was generated at the baseline and after 4 weeks of treatment. We also tested the effects of L-Arginine in vitro, measuring NO production, mitochondrial respiration, and gene expression in human fibroblasts. RESULTS: L-Arginine did not modify BMI, muscle strength, and maximal speed at 200 meters after 4 weeks. However, L-Arginine ameliorated oxidative metabolism to exercise as suggested by the statistically significant lower lactate-to-speed ratio, which was not observed in placebo-treated controls. In vitro, L-Arginine induced the expression of a key regulator of mitochondrial biogenesis (PGC1α) and genes encoding for complex I and increased the production of nitric oxide and the maximal oxygen consumption rate. CONCLUSIONS: Chronic L-Arginine is safe and effective in ameliorating the oxidative metabolism of professional water polo players, through a mechanism of enhanced mitochondrial function.
BACKGROUND: Ergogenic nutritional supplementation is sought by professional athletes for improving physical performance; nevertheless, scientific evidence to support the chronic use of L-Arginine among water polo players is missing. METHODS: Seventeen male professional water polo players were randomly assigned to assume 5 grams per day of L-Arginine (n = 9) or placebo (n = 8) for 4 weeks. The players' fitness level was assessed in the maximal speed swimming test. Ear lobe blood samples taken before and after the effort for serum lactate content were analyzed. A speed-to-lactate ratio was generated at the baseline and after 4 weeks of treatment. We also tested the effects of L-Arginine in vitro, measuring NO production, mitochondrial respiration, and gene expression in human fibroblasts. RESULTS: L-Arginine did not modify BMI, muscle strength, and maximal speed at 200 meters after 4 weeks. However, L-Arginine ameliorated oxidative metabolism to exercise as suggested by the statistically significant lower lactate-to-speed ratio, which was not observed in placebo-treated controls. In vitro, L-Arginine induced the expression of a key regulator of mitochondrial biogenesis (PGC1α) and genes encoding for complex I and increased the production of nitric oxide and the maximal oxygen consumption rate. CONCLUSIONS: Chronic L-Arginine is safe and effective in ameliorating the oxidative metabolism of professional water polo players, through a mechanism of enhanced mitochondrial function.
Authors: Clayton L Camic; Terry J Housh; Jorge M Zuniga; Russell C Hendrix; Michelle Mielke; Glen O Johnson; Richard J Schmidt Journal: J Strength Cond Res Date: 2010-05 Impact factor: 3.775
Authors: Anni Vanhatalo; Stephen J Bailey; Jamie R Blackwell; Fred J DiMenna; Toby G Pavey; Daryl P Wilkerson; Nigel Benjamin; Paul G Winyard; Andrew M Jones Journal: Am J Physiol Regul Integr Comp Physiol Date: 2010-08-11 Impact factor: 3.619
Authors: Raúl Bescós; Ferran A Rodríguez; Xavier Iglesias; Miguel D Ferrer; Elena Iborra; Antoni Pons Journal: Med Sci Sports Exerc Date: 2011-10 Impact factor: 5.411
Authors: Scott K Ferguson; Daniel M Hirai; Steven W Copp; Clark T Holdsworth; Jason D Allen; Andrew M Jones; Timothy I Musch; David C Poole Journal: J Physiol Date: 2012-10-15 Impact factor: 5.182